Healthcare · Biotechnology · Market cap $7.0B · $78.93 · 52-week range $11.86–$80.69
Open-market purchases reported to the SEC (last six months). Option grants and tax-withholding sales are excluded.
| Date | Insider | Role | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|
| 2026-05-19 | Caligan Partners LP | director, 10 percent owner, other: See Remarks | 5,300 | $59.98 | $317,894 | SEC Form 4 |
Last updated July 03, 2026.
ClearOcean is a software research tool, not an investment adviser or broker-dealer. This page aggregates public data (incl. SEC filings) for informational purposes only — it is not investment advice, nor a recommendation, offer or solicitation to buy or sell any security. Past activity does not predict future results. You are solely responsible for your decisions; investing can lose value, up to total loss of capital.